← Back to Screener
Oaktree Acquisition Corp. III Life Sciences Unit (OACCU)
Price$10.73
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-12.06%
Price vs S&P 500 (4W)-4.09%
VGM Score32.06
Market Capitalization$261.81M
All Metrics
Indicated Dividend (Annual)$0.00
Price vs S&P 500 (YTD)-10.99%
10-Day Avg Trading Volume0.00M
Quick Ratio (Quarterly)1.09x
3-Month Avg Trading Volume0.04M
52-Week High$10.74
26-Week Price Return1.53%
13-Week Price Return0.19%
Current Ratio (Quarterly)1.09x
3-Month Return Std Dev6.66%
Year-to-Date Return0.66%
5-Day Price Return-0.47%
Month-to-Date Return-0.28%
Price vs S&P 500 (13W)-10.47%
Beta0.01x
52-Week Low$10.30
mGradeD
vgmGradeD
Show chart for
Industry Peers — Blank Checks / SPACs(773)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
OACCUOaktree Acquisition Corp. III Life Sciences Unit | — | — | D | $10.73 |
| KCAC.WSKensington Capital Acquisition Corp. VI Class 1 redeemable warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 | F | A | A | $0.52 |
| WLACWillow Lane Acquisition Corp. Class A Ordinary Shares | — | C | A | $35.95 |
| CAEPCantor Equity Partners III, Inc. Class A Ordinary Shares | — | — | F | $6.90 |
| AACIUArmada Acquisition Corp. III Units | — | A | D | $10.08 |
| BACQRInflection Point Acquisition Corp. IV Right | — | D | D | $0.00 |
| BACQUInflection Point Acquisition Corp. IV Unit | — | D | D | $0.00 |
| AACIArmada Acquisition Corp. III Class A Ordinary Share | — | — | D | $9.95 |
| DMIIDrugs Made In America Acquisition II Corp. Ordinary Shares | — | — | C | $10.08 |
| DMIIRDrugs Made In America Acquisition II Corp. Right | — | — | C | $0.08 |
| DMIIUDrugs Made In America Acquisition II Corp. Unit | — | — | C | $10.15 |
About
Oaktree Acquisition Corp III Life Sciences is a special purpose acquisition company (SPAC) established to identify and acquire a life sciences company. The company seeks to combine with an operating business in the healthcare or life sciences sector through a merger or similar business combination. As a SPAC, it operates without current business operations pending the completion of a qualifying acquisition.